Among the Center’s elaborate plan to distribute the vaccine against the coronavirus disease (Covid-19), are the country’s air and road transport network and the sites where the vaccine will be administered to eligible people in the first phase. On Friday, the subject matter expert committee (SEC) of the Central Medicines …
Read More »70% to 80% reduction in participation in Covaxin phase 3 tests – official
The rejection rate of the phase 3 trial is much higher than that of the phase 1 and phase 2 trials, said Dr. Sanjay Rai. New Delhi: Although the phase 1 trial of its Covaxin vaccine obtained “encouraging” results, Hyderabad-based Bharat Biotech faces challenges in phase 3 trials of its …
Read More »59 percent of Indians are skeptical about the vaccine, will not rush to take it
With possibilities of affordable COVID-19 The vaccine is likely to be available by February 2021, 59 percent of Indians reported that they will not rush to take it, a poll revealed Wednesday. The last few weeks have given the world hope with three vaccine manufacturers: Pfizer, Modern and Oxford-AstraZeneca disclosing …
Read More »No complaints from volunteers who received Covaxin from Bharat Biotech: Ahmedabad doctor
The five healthy volunteers, who received an injection of the Covid-19 vaccine from Bharat Biotech International Limited at Sola Civil Hospital in Ahmedabad of Gujarat, have not complained of any health problems so far, a senior doctor said on Friday. During the phase 3 clinical trials of Covaxin, the first …
Read More »Chinese company seeks permission to launch covid vaccine for public use
A major Chinese vaccine developer has applied for authorization to bring its Covid-19 injection to market, seeking to get ahead of its western rivals as the race for a functional inoculation against the virus enters the home stretch. China National Biotec Group Co. has submitted a request to Chinese regulators, …
Read More »